Aurinia Pharmaceuticals (AUPH) Change in Acquisitions & Divestments (2020 - 2026)

Aurinia Pharmaceuticals has reported Change in Acquisitions & Divestments for 7 years, with the latest figure at $109.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 11.41% year-over-year to $109.0 million; the trailing twelve-month figure through Mar 2026 stood at $480.1 million (down 10.75% YoY), and the FY2025 full-year result was $494.1 million, down 15.59% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $109.0 million, down from $145.3 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $170.5 million in Q1 2024, with the low at $93.5 million in Q3 2025.
• Historically, Change in Acquisitions & Divestments has averaged $128.4 million across 5 years, with a median of $123.0 million in 2025.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments jumped 81.43% — and 2025, when it dropped 29.47%.
• Aurinia Pharmaceuticals' Change in Acquisitions & Divestments stood at $118.2 million in 2022, then rose by 16.82% to $138.1 million in 2023, then dropped by 10.22% to $124.0 million in 2024, then increased by 17.25% to $145.3 million in 2025, then declined by 25.01% to $109.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $109.0 million (Q1 2026), $145.3 million (Q4 2025), and $93.5 million (Q3 2025), per Business Quant data.